Keywords: germany, boehringer, ingelheim, posts, turnover, growth, first-half
Germany's Boehringer Ingelheim posts turnover growth for first-half 1999
Article | 12 August 1999
German drugmaker Boehringer Ingelheim says that sales for the first halfof 1999 were up more than 10% to 4.7 billion Deutschemarks ($2.57 billion), which ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Italy's pharma market slump set to continue, warns GlobalData
